Skip to content
GLP Loss
Legal

Terms of Use

Effective September 13, 2026

These Terms set out the agreement between you and GLP Loss (“we,” “us”) covering the website, the calculators, and anything else we publish here — together, the “Services.” They are binding, so they are worth reading before you rely on anything on the site. Using any part of the Services means you accept them and our Privacy Policy; if that does not suit you, the right course is simply not to use the site.

1. Acceptance of Terms

Reading a review, running a cost calculation, comparing two sellers or following a link out all count as use. In doing any of them you are confirming that you are 18 or older, or the age of majority where you live, and that these Terms are understood and accepted. Anyone acting for a company rather than themselves is confirming they can commit that company to them.

2. Description of Service

We publish research and reviews about GLP-1 medication and the telehealth sellers and pharmacies that supply it: what a month really costs, what the trials measured, and how sellers differ from one another. Nothing on this site is a clinical service. We hold no pharmacy license, employ no prescribers, write no prescriptions, dispense nothing, diagnose nobody, and form no doctor–patient relationship with anyone who reads us.

3. Not Medical Advice

Everything here is background reading. It is not a diagnosis, not a treatment plan, and not a substitute for either. Starting a GLP-1, stopping one, changing a dose or adding anything alongside it are all decisions for a licensed prescriber or pharmacist who knows your history — take them there, and take any question about a symptom there too. Do not put off advice, or set advice aside, because of something you read on this site. In an emergency, contact a doctor or your local emergency number rather than a website.

⛔ GLP-1 receptor agonists carry real risks — the labeled warnings include pancreatitis, gallbladder disease, kidney injury following dehydration, and a boxed warning about thyroid C-cell tumors seen in rodents — and they are not suitable for everyone. Much of what this site covers is compounded rather than FDA-approved, which means it has not been reviewed for safety, efficacy or quality before being dispensed. Acting on anything you read here is your own decision and your own risk.

4. User Conduct

You agree to use the Services only for lawful purposes and in a way that does not infringe the rights of, restrict, or inhibit anyone else's use of the Site. Prohibited conduct includes, without limitation: attempting to gain unauthorized access to any portion of the Site, its servers, or related systems; scraping or mass-copying content without permission; interfering with or disrupting the operation of the Site; uploading viruses, malware, or harmful code; harvesting email addresses or other contact information; and using the Site to harass, defame, or harm any person or entity.

5. Intellectual Property

All content on the Site that we create — including text, graphics, logos, research methodology, reviews, rankings, tools, charts, and the design and “look and feel” of the Site — is owned by GLP Loss or its licensors and is protected by United States and international copyright, trademark, and other intellectual property laws. You may view, download, and print content from the Site for your own personal, non-commercial use, and you may quote brief excerpts with attribution, provided you do not remove any copyright or other notices. You may not republish, scrape, sell, license, or otherwise commercially exploit substantial portions of our content without our prior written permission.

Provider names, brand names, logos, and trademarks referenced on the Site — including Geref® (EMD Serono), the discontinued branded form of GLP-1 acetate, and others — are the property of their respective owners. Their mention on the Site does not imply any affiliation with, endorsement by, or sponsorship from those companies unless we explicitly state otherwise.

6. Affiliate Links and Advertising

GLP Loss is a reader-supported publication. Many of the outbound links to providers on this Site are affiliate links, meaning that if you click a link and sign up or make a purchase we may earn a commission at no additional cost to you. Our commercial relationships may influence which providers we feature prominently, but they never influence our editorial assessments, scores, or safety statements. For full details, please see our Disclosures and Methodology.

7. Third-Party Links and Providers

The Site contains links to third-party websites, including provider sign-up pages, pharmaceutical manufacturer websites, scientific literature, and news sources. We do not control and are not responsible for the content, availability, privacy practices, or business practices of any third-party site. A link to a provider does not constitute an endorsement beyond what our review states. Before entering into any transaction with a third party, you should independently verify pricing, product availability, licensing, shipping terms, and applicable refund or cancellation policies.

8. Disclaimers

THE SERVICES ARE PROVIDED ON AN “AS IS” AND “AS AVAILABLE” BASIS WITHOUT WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED. TO THE FULLEST EXTENT PERMITTED BY LAW, GLP Loss DISCLAIMS ALL WARRANTIES, INCLUDING BUT NOT LIMITED TO IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, AND ACCURACY.

We make no warranty that (a) the Services will meet your requirements, (b) the Services will be uninterrupted, timely, secure, or error-free, (c) pricing information, availability, ingredient lists, clinical claims, or any other provider data will be accurate or current, or (d) any defects in the Services will be corrected. GLP-1 provider pricing and product offerings change frequently, and the science evolves; we do our best to keep information up to date, but you should verify every material detail directly with the provider before acting on it.

9. Limitation of Liability

TO THE MAXIMUM EXTENT PERMITTED BY LAW, IN NO EVENT SHALL GLP Loss, ITS AFFILIATES, OFFICERS, EMPLOYEES, AGENTS, OR LICENSORS BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, EXEMPLARY, OR PUNITIVE DAMAGES — INCLUDING WITHOUT LIMITATION LOST PROFITS, LOST REVENUE, LOST DATA, LOSS OF GOODWILL, PERSONAL INJURY, OR EMOTIONAL DISTRESS — ARISING OUT OF OR RELATED TO YOUR USE OF OR INABILITY TO USE THE SERVICES, WHETHER BASED ON WARRANTY, CONTRACT, TORT (INCLUDING NEGLIGENCE), STATUTE, OR ANY OTHER LEGAL THEORY, AND WHETHER OR NOT WE HAVE BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.

In jurisdictions that do not allow the exclusion or limitation of certain damages, our liability will be limited to the maximum extent permitted by law. In no event shall our aggregate liability to you for all claims arising out of or related to the Services exceed one hundred U.S. dollars (US$100).

10. Indemnification

You agree to defend, indemnify, and hold harmless GLP Loss, its affiliates, and their respective officers, directors, employees, and agents from and against any claims, liabilities, damages, losses, and expenses, including reasonable attorneys' fees, arising out of or in any way connected with your access to or use of the Services, your violation of these Terms, or your violation of any third-party right, including any intellectual property or privacy right.

11. Termination

We reserve the right, in our sole discretion and without notice, to suspend or terminate your access to all or any part of the Services at any time, with or without cause. Upon termination, all provisions of these Terms that by their nature should survive termination — including ownership provisions, warranty disclaimers, indemnification, and limitations of liability — will survive.

12. Changes to These Terms

We may revise these Terms from time to time. When we do, we will update the “Effective” date at the top of this page and, for material changes, take reasonable steps to notify users (for example, by posting a notice on the Site or sending an email to newsletter subscribers). Your continued use of the Services after changes become effective constitutes acceptance of the revised Terms.

13. Governing Law and Dispute Resolution

New York law governs these Terms and anything arising from them or from your use of the Services, setting aside its conflict-of-law rules. Any claim between us belongs in the state or federal courts sitting in New York, and by using the Services you accept that those courts have personal jurisdiction over you.

Nothing here limits a right you hold under the consumer-protection law of the state you live in, where that law says it cannot be waived.

14. Miscellaneous

These Terms, together with our Privacy Policy and Disclosures, constitute the entire agreement between you and GLP Loss regarding the Services. If any provision of these Terms is held to be invalid or unenforceable, the remaining provisions will remain in full force and effect. Our failure to enforce any right or provision of these Terms will not be considered a waiver of that right or provision.

15. Contact

Questions about these Terms can be sent to legal@glploss.com or by mail to:

GLP Loss
legal@glploss.com